HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gunderson, C. H. Search for Related Content PubMed PubMed Citation Articles by Gunderson, C. H.

The Impact of New Pharmaceutical Agents on the Cost of Neurologic Care

Article abstract-Since the emergence of the specialty, neurologists have worked with a rather restricted list of relatively inexpensive pharmacologic agents. This is rapidly changing with the development of new agents for the treatment of migraine, multiple sclerosis, Parkinson's disease, Alzheimer's disease, and epilepsy, accelerated in part by designation of the 1990s as the "Decade of the Brain". Exciting as these developments are, they are very costly when applied to the large number of patients who may benefit, perhaps exceeding $6.4 billion. Since this cost exceeds the $1.5 billion income of all practicing neurologists, it enhances the value of the neurologic consultation, which can provide more accurate diagnosis and more expertly directed therapy. Our relationships with the drug manufacturers are changing as our prescribing habits become a more likely determinant of profits.

NEUROLOGY 1995;45: 569-572

This article has been cited by other articles:

				R. G. Holloway, S. P. Ringel, J. L. Bernat, C. M. Keran, and B. L. Lawyer US neurologists: Attitudes on rationing Neurology, November 28, 2000; 55(10): 1492 - 1497. [Abstract] [Full Text] [PDF]

				S. P. Ringel and R. L. Hughes Evidence-Based Medicine, Critical Pathways, Practice Guidelines, and Managed Care: Reflections on the Prevention and Care of Stroke Arch Neurol, September 1, 1996; 53(9): 867 - 871. [Abstract] [PDF]